Acute Myeloid Leukemia

被引：134
|
作者：
Rubnitz, Jeffrey E. [1 ]
Gibson, Brenda [2 ]
Smith, Franklin O. [3 ]
机构：
[1] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA
[2] Royal Hosp Sick Children, Dept Paediat Haematol, Glasgow G3 8SJ, Lanark, Scotland
[3] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Med Ctr,Div Hematol Oncol, Cincinnati, OH 45221 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2010年 / 24卷 / 01期
关键词：
Myeloid; Leukemia; Childhood; MINIMAL RESIDUAL DISEASE; INTERNAL TANDEM DUPLICATION; BONE-MARROW-TRANSPLANTATION; ACUTE-MYELOGENOUS-LEUKEMIA; CHILDRENS-CANCER-GROUP; ACUTE PROMYELOCYTIC LEUKEMIA; PEDIATRIC-ONCOLOGY-GROUP; HIGH-DOSE CYTARABINE; AMEGAKARYOCYTIC THROMBOCYTOPENIC PURPURA; ACUTE MEGAKARYOBLASTIC LEUKEMIA;
D O I：
10.1016/j.hoc.2009.11.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Acute myeloid leukemia (AML) is a heterogeneous group of leukemias that result from clonal transformation of hematopoietic precursors through the acquisition of chromosomal rearrangements and multiple gene mutations. As a result of highly collaborative clinical research by pediatric cooperative cancer groups worldwide, disease-free survival has improved significantly during the past 3 decades. Further improvements in outcomes of children who have AML probably will reflect continued progress in understanding the biology of AML and the concomitant development of new molecularly targeted agents for use in combination with conventional chemotherapy drugs.
引用
收藏
页码：35 / +
页数：30
相关论文
共 50 条
  • [1] Treatment strategies for pediatric acute myeloid leukemia
    Absalon, Michael J.
    Smith, Franklin O.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (01) : 57 - 79
  • [2] Progress in Acute Myeloid Leukemia
    Kadia, Tapan M.
    Ravandi, Farhad
    O'Brien, Susan
    Cortes, Jorge
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (03): : 139 - 151
  • [3] Pediatric acute myeloid leukemia
    Kaspers, Gertjan J. L.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (03) : 405 - 413
  • [4] Clinical implications of molecular markers in acute myeloid leukemia
    Kayser, Sabine
    Levis, Mark J.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (01) : 20 - 35
  • [5] Molecular biomarkers in acute myeloid leukemia
    Prada-Arismendy, Jeanette
    Arroyave, Johanna C.
    Rothlisberger, Sarah
    BLOOD REVIEWS, 2017, 31 (01) : 63 - 76
  • [6] Cytogenetics of pediatric acute myeloid leukemia
    Manola, Kalliopi N.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (05) : 391 - 405
  • [7] Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
    Zwaan, C. Michel
    Kolb, Edward A.
    Reinhardt, Dirk
    Abrahamsson, Jonas
    Adachi, Souichi
    Aplenc, Richard
    De Bont, Eveline S. J. M.
    De Moerloose, Barbara
    Dworzak, Michael
    Gibson, Brenda E. S.
    Hasle, Henrik
    Leverger, Guy
    Locatelli, Franco
    Ragu, Christine
    Ribeiro, Raul C.
    Rizzari, Carmelo
    Rubnitz, Jeffrey E.
    Smith, Owen P.
    Sung, Lillian
    Tomizawa, Daisuke
    van den Heuvel-Eibrink, Marry M.
    Creutzig, Ursula
    Kaspers, Gertjan J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (27) : 2949 - +
  • [8] Frontline treatment of acute myeloid leukemia in adults
    Tamamyan, Gevorg
    Kadia, Tapan
    Ravandi, Farhad
    Borthakur, Gautam
    Cortes, Jorge
    Jabbour, Elias
    Daver, Naval
    Ohanian, Maro
    Kantarjian, Hagop
    Konopleva, Marina
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 110 : 20 - 34
  • [9] Overview of Therapy and Strategies for Optimizing Outcomes in De Novo Pediatric Acute Myeloid Leukemia
    Faulk, Kelly
    Gore, Lia
    Cooper, Todd
    PEDIATRIC DRUGS, 2014, 16 (03) : 213 - 227
  • [10] The genomics of acute myeloid leukemia in children
    Conneely, Shannon E.
    Rau, Rachel E.
    CANCER AND METASTASIS REVIEWS, 2020, 39 (01) : 189 - 209
12345